MTOR inhibitors - PDFSEARCH.IO - Document Search Engine

MTOR inhibitors
Results: 14

#	Item
1	EISAI AND PIQUR SIGN LANDMARK COLLABORATION AGREEMENT TO INVESTIGATE HALAVEN® (ERIBULIN) AND PQR309 IN HARD TO TREAT FORM OF BREAST CANCER Agreement will see eribulin used in combination with novel PI3K/mTOR inhibitor i Add to Reading List Source URL: www.piqur.com Language: English - Date: 2016-02-17 03:09:52 Clinical medicine Medicine Cancer Antineoplastic drugs Cancer treatments Signal transduction Breast cancer Macrolides Eribulin Halichondrin B MTOR inhibitors Eisai
2	MuTaLig COST ACTION CA15135 st 1 Annual meeting 2016 USI Lugano(CH), JulyPoster list Add to Reading List Source URL: www.mutalig.eu Language: English - Date: 2016-07-12 08:10:41 Medicinal chemistry Signal transduction Oncology Drug discovery Tyrosine kinase receptors MTOR inhibitors Mechanistic target of rapamycin Phosphoinositide 3-kinase Quantitative structureactivity relationship C-Met
3	Media Release Basel (Switzerland), May 28, 2015 PIQUR announces positive Phase 1 study results and the start of Phase 2 of PQR309 Study confirms that PQR309 is well tolerated and shows promising signs of Add to Reading List Source URL: www.piqur.com Language: English - Date: 2015-05-28 07:07:33 Signal transduction Oncology MTOR inhibitors Mechanistic target of rapamycin Phosphoinositide 3-kinase Phosphoinositide 3-kinase inhibitor C-Met Sirolimus Wortmannin
4	PLoS BIOLOGY Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2 Morris E. Feldman1, Beth Apsel1, Aino Uotila2, Robbie Loewith2, Zachary A. Knight1¤, Davide Ruggero3, Add to Reading List Source URL: knightlab.ucsf.edu Language: English - Date: 2013-08-14 14:37:47
5	PLoS BIOLOGY Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2 Morris E. Feldman1, Beth Apsel1, Aino Uotila2, Robbie Loewith2, Zachary A. Knight1¤, Davide Ruggero3, Add to Reading List Source URL: molbio.unige.ch Language: English - Date: 2011-06-08 05:03:15
6	Skin cancer in solid organ transplant recipients: are mTOR inhibitors a game changer? Add to Reading List Source URL: www.transplantationresearch.com Language: English
7	Combinatorial Testing of an ERK Inhibitor, SCHwith PI3K/AKT/mTOR Inhibitors in Melanoma Master Thesis In order to obtain the academic degree Add to Reading List Source URL: www.marshallplan.at Language: English - Date: 2015-02-11 08:30:50 Cell biology Biochemistry Oncogenes C-Raf Vemurafenib BRAF PI3K/AKT/mTOR pathway Raf kinase AKT Biology Signal transduction Protein kinases
8	Review series Rapalogs and mTOR inhibitors as anti-aging therapeutics Dudley W. Lamming,1,2 Lan Ye,3 David M. Sabatini,1,2 and Joseph A. Baur3 1Whitehead Institute for Biomedical Research, Department of Biology, Howard Add to Reading List Source URL: sabatinilab.wi.mit.edu Language: English - Date: 2015-04-21 13:21:14 Immunosuppressants Chemistry Gerontology Mammalian target of rapamycin Signal transduction Kidney cancer Sirolimus Insulin-like growth factor 1 Zotarolimus Medicine Biology Macrolides
9	Have Results of Recent Randomized Trials Changed the Role of mTOR Inhibitors? Bernard Escudier Institut Gustave Roussy Add to Reading List Source URL: www.euikcs.com Language: English - Date: 2015-05-04 13:05:46 Macrolides Orphan drugs Organofluorides Pyridines Immunosuppressants Temsirolimus Sunitinib Sorafenib Everolimus Chemistry Organic chemistry Medicine
10	Vicier et al. Breast Cancer Research 2014, 16:203 http://breast-cancer-research.com/contentREVIEW Clinical development of mTOR inhibitors in breast Add to Reading List Source URL: breast-cancer-research.com Language: English Immunosuppressants Ribbon symbolism Breast cancer Signal transduction Everolimus Mammalian target of rapamycin Breast cancer treatment Phosphoinositide 3-kinase inhibitor AKT Medicine Biology Macrolides